Skip to main content
. 2013 Nov 1;2013(3):269–278. doi: 10.5339/gcsp.2013.34

Figure 1. .

Figure 1. 

The effect of treatment on all-cause mortality in ACE inhibitor and ARB hypertension trials. The effect of treatment on all-cause mortality was significant with ACE inhibitors (p = 0.004), but not with ARBs (p = 0.683). Copied from reference.6Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; CI, confidence interval; HR, hazard ratio.